Molecular mechanisms of congenital heart disease

Cardiovascular Pathology

Volumn 19, Issue 5, 2010, Pages

  Jing Bin, Huang ^a   Ying Long, Liu ^a   Pei Wu, Sun ^b   Xiao Dong, Lv ^a   Ming, Du ^a   Xiang Ming, Fan ^a  

^a FUWAI HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Congenital heart disease; Genetics; Molecular mechanism

Indexed keywords

ELASTIN; FIBRILLIN 1; JAGGED1; K RAS PROTEIN; LEFT RIGHT DETERMINATION FACTOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 11; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACVR2B GENE; BIOINFORMATICS; CFC1 GENE; CHD7 GENE; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; CRELD1 GENE; ELLIS VAN CREVELD SYNDROME; EPIGENETICS; GENE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETICS; HEART DEVELOPMENT; HEART HEMODYNAMICS; HEREDITY; HRAS GENE; HUMAN; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSIT240 GENE; REVIEW; SOS1 GENE; ZIC3 GENE;

ANIMALS; HEART DEFECTS, CONGENITAL; HUMANS; MOLECULAR BIOLOGY;

EID: 77956428378     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2009.06.008     Document Type: Review

References (91)

1. Hoffman JI, and Kaplan S The incidence of congenital heart disease J Am Coll Cardiol 39 2002 1890 1900
2. Garg V. Insights into the genetic basis of congenital heart disease Cell Mol Life Sci 63 10 2006 1141 1148
3. Kohl HW 3rd. Rubella screening and vaccination follow-up by a hospital employee health office Am J Infect Control 13 3 1985 124 127
4. Singh M, Shah GL, and Singh KP Teratogenic effects of dilantin on thoraco-abdominal organs of developing chick embryos Indian J Exp Biol 38 10 2000 1026 1030
5. Dawson BV, Johnson PD, and Goldberg SJ Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water J Am Coll Cardiol 21 6 1993 1466 1472
6. Kumar SD, Dheen ST, and Tay SS Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development Cardiovasc Diabetol 6 2007 34
7. McCart A, Latchford A, and Volikos E A novel exon duplication event leading to a truncating germ-line mutation of the APC gene in a familial adenomatous polyposis family Fam Cancer 5 2 2006 205 208
8. Kakavas VK, Plageras P, and Vlachos TA PCR-SSCP: a method for the molecular analysis of genetic diseases Mol Biotechnol 38 2 2008 155 163
9. Moorman AF, and Christoffels VM Cardiac chamber formation: development, genes, and evolution Physiol Rev 83 4 2003 1223 1267
10. Michael E, Mitchell L, and Tara L The molecular basis of congenital heart disease Semin Thorac Cardiovasc Surg 19 3 2007 228 237
11. Dunwoodie SL Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation Semin Cell Dev Biol 18 1 2007 54 66
12. Brand T Heart development: molecular insights into cardiac specification and early morphogenesis Dev Biol 258 1 2003 1 19
13. Gruber PJ, and Epstein JA. Development gone awry congenital heart disease Circ Res 94 3 2004 273 283
14. Grego-Bessa J, Luna-Zurita L, and del Monte G Notch signaling is essential for ventricular chamber development Dev Cell 12 2007 415 429
15. Risebro CA, and Riley PR Formation of the ventricles Sci World J 6 2006 1862 1880
16. Cohen ED, Tian Y, and Morrisey EE Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal Development 135 5 2008 789 798
17. Xiao H, and Zhang YY Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models Clin Exp Pharmacol Physiol 35 3 2008 335 341
18. Moon JI, and Birren SJ Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway Dev Biol 315 2 2008 404 417
19. Mjaatvedt CH, Nakaoka T, and Moreno-Rodriguez R The outflow tract of the heart is recruited from a novel heart-forming field Dev Biol 238 1 2001 97 109
20. Bruneau BG The developmental genetics of congenital heart disease Nature 451 7181 2008 943 948
21. High FA, and Epstein JA The multifaceted role of Notch in cardiac development and disease Nat Rev Genet 9 1 2008 49 61
22. Armstrong EJ, and Bischoff J Heart valve development: endothelial cell signaling and differentiation Circ Res 3 95(5) 2004 459 470
23. Yutzey KE, Colbert M, and Robbins J Ras-related signaling pathways in valve development: ebb and flow Physiology (Bethesda) 20 2005 390 397
24. Joziasse IC, van de Smagt JJ, and Smith K Genes in congenital heart disease: atrioventricular valve formation Basic Res Cardiol 103 3 2008 216 227
25. Pierpont ME, Basson CT, and Benson DW Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics Circulation 115 2007 3015 3038
26. Ikeda Y, Hiroi Y, and Hosoda T Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease Circ J 66 2002 561 563
27. McElhinney DB, Geiger E, and Blinder J NKX2.5 mutations in patients with congenital heart disease J Am Coll Cardiol 42 2003 1650 1655
28. Elliott DA, Kirk EP, and Yeoh T Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome J Am Coll Cardiol 41 2003 2072 2076
29. Schubbert S, Zenker M, and Rowe SL Germline KRAS mutations cause Noonan syndrome Nat Genet 38 2006 331 336
30. Tartaglia M, Kalidas K, and Shaw A PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity Am J Hum Genet 70 2002 1555 1563
31. Toko H, Zhu W, and Takimoto E Csx/Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart J Biol Chem 277 27 2002 24735 24743
32. Akazawa H, and Komuro I. Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases Pharmacol Ther 107 2 2005 252 268
33. Goldmuntz E, Bamford R, and Karkera JD CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle Am J Hum Genet 70 3 2002 776 780
34. Davit-Spraul A, Baussan C, and Hermeziu B CFC1 gene involvement in biliary atresia with polysplenia syndrome J Pediatr Gastroenterol Nutr 46 1 2008 111 112
35. Muncke N, Jung C, and Rüdiger H Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries) Circulation 108 23 2003 2843 2850
36. Finelli P, Pincelli AI, and Russo S Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis Clin Genet 71 3 2007 195 204
37. Heritage ML, MacMillan JC, and Anderson GJ DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations in Australian Alagille syndrome patients Hum Mutat 20 6 2002 481
38. Robinson SW, Morris CD, and Goldmuntz E Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects Am J Hum Genet 72 4 2003 1047 1052
39. Tomita-Mitchell A, Maslen CL, and Morris CD GATA4 sequence variants in patients with congenital heart disease Eur J Med Genet 51 6 2008 527 535
40. Zhu L, Zhou G, and Poole S Characterization of the interactions of human ZIC3 mutants with GLI3 Hum Mutat 29 1 2008 99 105
41. Harrison CA, Gray PC, and Fischer WH An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors J Biol Chem 279 27 2004 28036 28044
42. Besser D Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3 J Biol Chem 279 43 2004 45076 45084
43. Ferland RJ, Gaitanis JN, and Apse K Periventricular nodular heterotopia and Williams syndrome Am J Med Genet A 140 12 2006 1305 1311
44. Fan C, Liu M, and Wang Q Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome J Biol Chem 278 10 2003 8780 8785
45. Zhao F, Weismann CG, and Satoda M Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation Am J Hum Genet 69 4 2001 695 703
46. Ko JM, Kim JM, and Kim GH PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome J Hum Genet 53 11-12 2008 999 1006
47. Roberts AE, Araki T, and Swanson KD Germline gain-of-function mutations in SOS1 cause Noonan syndrome Nat Genet 39 1 2007 70 74
48. Wincent J, Holmberg E, and Strömland K CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome Clin Genet 74 1 2008 31 38
49. Temtamy SA, Aglan MS, and Valencia M CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome Hum Mutat 29 7 2008 931 938
50. Ulucan H, Gül D, and Sapp JC Extending the spectrum of Ellis van Creveld syndrome: a large family with a mild mutation in the EVC gene BMC Med Genet 9 2008 92
51. Li D, Yu J, and Gu F The roles of two novel FBN1 gene mutations in the genotype-phenotype correlations of Marfan syndrome and ectopia lentis patients with marfanoid habitus Genet Test 12 2 2008 325 330
52. Singh KK, Rommel K, and Mishra A TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome Hum Mutat 27 8 2006 770 777
53. Niihori T, Aoki Y, and Narumi Y Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome Nat Genet 38 3 2006 294 296
54. Roberts A, Allanson J, and Jadico SK The cardiofaciocutaneous syndrome J Med Genet 43 11 2006 833 842
55. Nava C, Hanna N, and Michot C Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome J Med Genet 44 12 2007 763 771
56. Quezada E, and Gripp KW Costello syndrome and related disorders Curr Opin Pediatr 19 6 2007 636 644
57. Clark EB Mechanisms in the pathogenesis of congenital heart disease ME Pierpont, J Moller, The genetics of cardiovascular disease 1986 Martinus-Nijoff Boston, MA 3 11
58. Clark EB Pathogenetic mechanisms of congenital cardiovascular malformations revisited Semin Perinatol 20 1996 465 472
59. Benoit G. Bruneau. The developmental genetics of congenital heart disease Nature 451 7181 2008 943 948
60. Hyun C, and Lavulo L. Congenital heart diseases in small animals: part I. Genetic pathways and potential candidate genes Vet J 171 2 2006 245 255 (Pubitemid 43257228)
61. Hiroi Y, Kudoh S, and Monzen K Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation Nat Genet 28 3 2001 276 280
62. Goldmuntz E, Geiger E, and Benson DW NKX2.5 mutations in patients with tetralogy of Fallot Circulation 104 21 2001 2565 2568
63. Stennard FA, Costa MW, and Elliott DA Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart Dev Biol 262 2 2003 206 224
64. Pashmforoush M, Lu JT, and Chen H Nkx2-5 pathways and congenital heart disease: loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block Cell. 117 3 2004 373 386
65. Pu WT, Ishiwata T, and Juraszek AL GATA4 is a dosage-sensitive regulator of cardiac morphogenesis Dev Biol 275 1 2004 235 244
66. Moskowitz IP, Kim JB, and Moore ML A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development Cell 129 7 2007 1365 1376
67. Ching YH, Ghosh TK, and Cross SJ Mutation in myosin heavy chain 6 causes atrial septal defect Nat Genet 37 4 2005 423 428
68. Varadkar P, Kraman M, and Despres D Notch2 is required for the proliferation of cardiac neural crest-derived smooth muscle cells Dev Dyn 237 4 2008 1144 1152
69. Del Monte G, Grego-Bessa J, and González-Rajal A Monitoring Notch1 activity in development: evidence for a feedback regulatory loop Dev Dyn 236 9 2007 2594 2614
70. Kwon C, Arnold J, and Hsiao EC Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors Proc Natl Acad Sci U S A 104 26 2007 10894 10899
71. Miller CT, Swartz ME, and Khuu PA mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish Dev Biol 308 1 2007 144 157
72. Ren X, Li Y, and Ma X Activation of p38/MEF2C pathway by all-trans retinoic acid in cardiac myoblasts Life Sci 81 2 2007 89 96 (Pubitemid 46921175)
73. Ueno S, Weidinger G, and Osugi T Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells Proc Natl Acad Sci U S A 104 23 2007 9685 9690
74. Groenendijk BC, Stekelenburg-de Vos S, and Vennemann P The endothelin-1 pathway and the development of cardiovascular defects in the haemodynamically challenged chicken embryo J Vasc Res 45 1 2008 54 68
75. Couzin J. Breakthrough of the year: small RNAs make big splash Science. 298 5602 2002 2296 2297
76. Liu CG, Calin GA, and Meloon B An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues Proc Natl Acad Sci U S A 101 26 2004 9740 9744
77. Lee CT, Risom T, and Strauss WM MicroRNAs in mammalian development Birth Defects Res C Embryo Today 78 2 2006 129 139
78. Zhang B, Wang Q, and Pan X MicroRNAs and their regulatory roles in animals and plants J Cell Physiol 210 2 2007 279 289
79. Zhao Y., Ransom JF, and Li A Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 Cell. 129 2 2007 303 317
80. Zhao Y, Samal E, and Srivastava D Serum sponse factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature. 436 7048 2005 214 220
81. Kwon C, Han Z, and Olson EN MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling Proc Natl Acad Sci U S A 102 52 2005 18986 18991
82. Wong AH, Gottesman II, and Petronis A Phenotypic differences in genetically identical organisms: the epigenetic perspective Hum Mol Genet 14 1 2005 R11 R18
83. Armstrong L, Lako M, and Dean W Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer Stem Cells 24 4 2006 805 814
84. Jacinto FV, and Esteller M Mutator pathways unleashed by epigenetic silencing in human cancer Mutagenesis 22 4 2007 247 253
85. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 46 2005 1 8
86. Cambien F, and Tiret L Genetics of cardiovascular diseases: from single mutations to the whole genome Circulation 116 2007 1714 1724
87. Gatzoulis MA Adult congenital heart disease: a cardiovascular area of growth in urgent need of additional resource allocation Int J Cardiol 97 Suppl 1 2004 1 2
88. Cohen JC Genetic approaches to coronary heart disease J Am Coll Cardiol 48 2006 A10 A14
89. Wallace C, Newhouse SJ, and Braund P Genomewide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia Am J Hum Genet 82 2008 139 149
90. Todd AK Bioinformatics approaches to quadruplex sequence location Methods 43 4 2007 246 251
91. Yang W, and Paschen W Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter Biochem Biophys Res Commun 365 3 2008 521 527